Holdings of Checkpoint Capital L.P.
· Original filing · Compare with another fund · Report an error
- Net assets
- -
- Positions
- 8 in 2 countries
- Top ten
- 100.0 % of the equity sleeve
- Filed on
- Mar 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Argenx SE | 153,000 | 111.7M $ | |
| 2 | Rhythm Pharmaceuticals Inc | 1,227,200 | 106.7M $ | |
| 3 | Revolution Medicines Inc | 262,539 | 25.5M $ | |
| 4 | Disc Medicine Inc | 286,661 | 18.3M $ | |
| 5 | Cytokinetics Inc | 180,000 | 11.9M $ | |
| 6 | Septerna Inc | 100,300 | 2.4M $ | |
| 7 | Crinetics Pharmaceuticals Inc | 40,230 | 1.5M $ | |
| 8 | Trevi Therapeutics Inc | 50,000 | 596.5K $ |
Sector breakdown
- Health care 40.1 %
- Unattributed 59.9 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 100.0 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 59.9 %
- Netherlands 40.1 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 7 | 166.9M $ | 59.90 % |
| 2 | Netherlands | 1 | 111.7M $ | 40.10 % |
Cite this page
Titelia. "Holdings of Checkpoint Capital L.P.". https://titelia.com/en/funds/US13F1977548